|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 49/00 | (2006.01) | ||
| A61K 49/16 | (2006.01) | ||
| G01N 33/564 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 21/04 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/14 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 3215527 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15857258.6 |
| Date of filing the European patent application | 2015-11-05 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-08 |
| (46) | Date of publication of the claims translation | 2025-04-10 |
| (86) | Number | PCT/US2015/059185 |
| Date | 2015-11-05 |
| (87) | Number | WO 2016/073685 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 201462075793 P | 2014-11-05 | US |
| (72) |
ROSENTHAL, Arnon , US
LEVITEN, Michael , US
|
| (73) |
Annexon, Inc. ,
1400 Sierra Point Parkway
Building C, 2nd Floor, Brisbane, CA 94005,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuoti antikūnai prieš komplemento faktorių C1Q ir jų panaudojimas |
| HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-09-26 | 11 | 289.00 EUR |
| 2026-11-05 |